DTL
ALLO icon

Dynamic Technology Lab’s Allogene Therapeutics ALLO Stock Holding History

Dynamic Technology Lab’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.2K Buy
+18,122
New +$36.3K 0.01% 817
2025
Q4 		– Sell
-39,677
Closed -$50K – 718
2025
Q3 		$50K Buy
+39,677
New +$47.3K 0.01% 754
2024
Q3 		– Sell
-14,085
Closed -$33K – 992
2024
Q2 		$33K Buy
+14,085
New +$41.6K ﹤0.01% 892
2023
Q3 		– Sell
-33,095
Closed -$164K – 933
2023
Q2 		$164K Buy
+33,095
New +$179K 0.02% 855
2022
Q4 		– Sell
-46,452
Closed -$501K – 1061
2022
Q3 		$501K Buy
+46,452
New +$631K 0.05% 626
2021
Q3 		– Sell
-7,920
Closed -$207K – 1036
2021
Q2 		$207K Buy
+7,920
New +$226K 0.02% 930

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return